Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Noble Corporation reported Q3 2026 financial results with total revenue of $729 million and a net loss of $117 million. The company secured $560 million in new contract awards since July, bringing its total backlog to $6.7 billion, and declared a $0.50 per share quarterly dividend.
“The third quarter, which featured a 5% sequential decrease in Adjusted EBITDA, marked the successful resumption of operations for both of our rigs in Brazil, but was also impacted by several other rigs across the fleet transitioning between contracts. On the commercial front, we have recently secured approximately $560 million in new contract awards, including a number of key programs that support a strengthening fleet utilization profile as we move through 2027.”
Robert W. Eifler, President and Chief Executive Officer
New Mountain Finance Corporation's board of directors has approved a one-year extension of its existing $150 million stock repurchase program through December 31, 2027. The company has repurchased approximately $70 million worth of shares to date under the program, leaving $80 million in remaining authorization. The extension allows management to continue repurchasing shares in the open market if they believe the stock is undervalued due to market volatility.
Bone Biologics Corp reported a net loss of $2,157,341 for the nine months ended September 30, 2026, compared to a loss of $2,424,348 in the prior year period. The company remains in the development stage with zero revenue, focusing its expenditures on research and development for its NELL-1/DBM product candidate.
DataMeds AI M&A Deal with EOS Technology Holdings, Inc.
DataMEDS AI entered into a second amended and restated non-binding letter of intent to acquire intellectual property assets from EOS and Scilex Holding Company, and a controlling interest in Tollo Health (d/b/a Health Lives Here). The transaction involves an exchange of membership interests and the issuance of common stock that will result in the counterparties owning approximately 89.5% of the company's common stock on a fully diluted basis.
Eva Live $742K Debt Financing with Streeterville Capital, LLC
Eva Live Inc. received a notice from Streeterville Capital, LLC asserting that a 'Major Trigger Event' occurred under two secured convertible promissory notes due to a restricted issuance. As a result, Streeterville has elected to increase the outstanding balance of the notes by 10%, an estimated increase of approximately $741,786. The company disputes these assertions and the validity of the increase.
Par Chadha, Chairman of the Board of Directors, notified XBP Global Holdings that he will not stand for re-election at the company's next annual meeting of stockholders. Mr. Chadha will continue to serve as Chairman until the expiration of his current term, and his departure is not due to any disagreement with the company.
Blue Ridge Bankshares reported a net loss of $4.2 million for the third quarter of 2026, primarily driven by an $8.5 million pre-tax provision for credit losses related to a legacy out-of-market hydroponic farming relationship. Despite the loss, the company noted improved operating performance with adjusted pre-tax earnings rising to $5.3 million and a pending merger with HomeTrust Bancshares expected to close in Q1 2027.
Term
Q3 2026
“With the regulatory consent order lifted in late 2025, our focus this year turned to soundness, profitability, and growth in our core community bank markets. Our third quarter results reflect continued quarterly improvements in loan growth, loan yields, deposit mix, and noninterest expense discipline. In addition, we further de-risked the balance sheet with a substantial charge-off on a legacy out-of-footprint relationship operating in the hydroponic farming business.”
Harry Golliday, interim president and chief executive officer
Fold Holdings stockholders approved a proposal to authorize the Board of Directors to effect a reverse stock split of the company's common stock at a ratio between 1-for-2 and 1-for-50. The final decision on the exact ratio and timing remains at the discretion of the Board following this approval.
YHN Acquisition I Limited received a Staff Determination notice from Nasdaq on October 21, 2026, stating that the company failed to regain compliance with minimum market value requirements for continued listing. The company's board has decided not to appeal the delisting or transfer to the Nasdaq Capital Market, and trading is expected to be suspended on October 30, 2026. The company intends to apply for quotation on the OTC Markets following the delisting.
Smartfinancial Director Steven B. Tucker Sells $173K of Stock
Steven B. Tucker, Director, sold 3,500 shares of Smartfinancial Inc. at $49.50 a share, worth $173K in total on Oct 23, 2026. Shares held after the trade: 47,222 (-6.9%).
Zeo Energy Corp. received a 180-day extension from Nasdaq, until April 19, 2027, to regain compliance with the $1.00 minimum bid price requirement. The company's Class A common stock will continue to trade on the Nasdaq Capital Market during this period while management monitors the stock price and considers options to meet the listing standard.
Lycia Therapeutics, Inc. filed its Amended and Restated Certificate of Incorporation and Bylaws in connection with the closing of its initial public offering. These governance changes were previously approved by the board and stockholders to take effect upon the IPO's completion.
Nucor Corporation reported Q3 2026 net earnings of $1.32 billion on net sales of $11.25 billion, driven by strong demand and higher average selling prices in its steel mills segment. The company generated $2.7 billion in free cash flow year-to-date and achieved operational milestones including the first heat at its West Virginia sheet mill.
Term
Q3 2026
“I want to thank our teammates for delivering another strong quarter and making 2026 the safest summer in Nucor history. Supported by robust demand across key end markets, Nucor has generated approximately $2.7 billion of free cash flow and returned nearly $1.4 billion to shareholders through the first nine months of the year.”
Leon Topalian, Nucor’s Chair and Chief Executive Officer
“We also achieved important milestones in advancing our growth strategy, including the first heat at our West Virginia sheet mill in September and the recent start-up of our second galvanizing line at Nucor Steel Berkeley. These projects, together with other recent investments, are expanding Nucor’s capabilities and strengthening our position in attractive markets.”
Leon Topalian, Nucor’s Chair and Chief Executive Officer
Bank of Hawaii reported net income of $64.3 million for the third quarter of 2026, an increase from $53.3 million in the same period of 2025. Total assets decreased slightly to $23.8 billion as of September 30, 2026, compared to $24.2 billion at year-end 2025, primarily driven by a reduction in cash and cash equivalents and held-to-maturity investment securities.
Rallybio Signs $82.7M M&A Deal with Avenzo Therapeutics, Inc.
Rallybio Corporation provided a status update on its pending merger with Avenzo Therapeutics, declaring a special cash distribution of approximately $82.7 million ($13.56 per share) to stockholders. The distribution is based on the company's estimated net cash exceeding zero prior to the merger closing and is scheduled for payment on November 13, 2026.
Apollo Asset Backed Credit Co Capital Raise of $34.7M
Apollo Asset Backed Credit Company LLC issued and sold unregistered shares across multiple classes for total aggregate consideration of approximately $34.73 million as of October 1, 2026. The company also disclosed its Transactional Net Asset Value (NAV) per share as of September 30, 2026, which serves as the pricing basis for ongoing sales and its quarterly share repurchase program.
Alpha Cognition Insider Opaleye Management Inc. Buys $266K of Stock
Opaleye Management Inc. bought 32,090 shares of Alpha Cognition Inc. at $8.23 to $8.33 a share (average $8.28) in 2 transactions, worth $266K in total between Oct 22, 2026 and Oct 23, 2026. Shares held after the trade: 3,291,984 (+0.5%).
Charles River Laboratories International Insider James C. Foster Sells $8.41M of Stock
James C. Foster sold 24,042 shares of Charles River Laboratories International, Inc. at $350.00 a share, worth $8.41M in total on Oct 22, 2026. Shares held after the trade: 31,596 (-43.2%).
Boundless Bio 10% Owner Kevin Tang Buys $51.6K of Stock
Kevin Tang, 10% Owner, bought 21,640 shares of Boundless Bio, Inc. at $2.38 to $2.40 a share (average $2.39) in 3 transactions, worth $51.6K in total between Oct 22, 2026 and Oct 26, 2026. Shares held after the trade: 3,011,749 (+0.3%).
Standex International Corporation appointed Brenna D. Preisser as a Class I director, effective January 1, 2027, succeeding the retiring B. Joanne Edwards. Ms. Preisser, currently an Executive Vice President at Brunswick Corporation, will receive a $150,000 restricted stock award and standard non-employee director compensation.
Genvor Incorporated entered into an Intellectual Property Assignment Agreement with its founder and Chief Scientific Officer, Dr. Jesse Jaynes. Dr. Jaynes assigned the rights to approximately 9,000 synthetic antimicrobial peptide sequences and associated validation data to the company for use in its research and commercialization programs.
Soren Acquisition Corp. implemented a planned leadership transition, appointing Joseph Tonnos as Chief Financial Officer and a director, succeeding Jamie Weber. Additionally, Roger Cloutier Jr. and Austin Criden were appointed to the board following the resignations of Spencer Gerrol and Charles N. Kahn III. These changes are part of a broader alignment with the Di Rezze Family Office, which sponsors the SPAC.
Mirum Pharmaceuticals announced positive results from Cohort 2 of its pivotal PROGRESS study evaluating ATEBRIOZ (zilurgisertib) in pediatric patients aged 6 to <12 with fibrodysplasia ossificans progressiva (FOP). The study met its endpoints with a significant reduction in total heterotopic ossification lesion volume and improved joint mobility compared to placebo, supporting a planned sNDA submission in the first half of 2027.
Kinetik Holdings subsidiary EagleClaw Midstream Ventures reached a settlement with Energy Transfer to resolve a dispute regarding the expiration date of an NGL purchase agreement. The parties confirmed the agreement will terminate on December 31, 2026, while a second agreement remains subject to ongoing litigation awaiting adjudication.
Longeveron announced updated Phase 2b ELPIS II trial results for laromestrocel in infants with hypoplastic left heart syndrome (HLHS). While the trial missed its primary efficacy endpoint of RVEF change, additional analysis showed the secondary endpoint of major adverse cardiac events (MACE) achieved statistical significance with only 1 event in the treatment arm versus 8 in the standard of care arm (P=0.043).
Capital City Bank Group Director William F. Butler Buys $20K of Stock
William F. Butler, Director, bought 392 shares of Capital City Bank Group Inc at $51.07 a share, worth $20K in total on Oct 26, 2026. Shares held after the trade: 7,137 (+5.8%).
Flexsteel Industries reported fiscal first quarter 2027 net sales of $114.0 million, a 3.2% increase year-over-year, driven by 5.1% growth in Flexsteel branded products. GAAP net income per diluted share was $1.24, down from $1.31 in the prior year quarter, impacted by foreign currency headwinds and rising ocean transportation and material costs.
Term
Q1 2027
“I'm pleased with our first quarter results and the continued momentum of our growth strategies despite a challenging macroeconomic environment. Net sales increased 3.2 percent compared to the prior year, toward the upper end of our guidance range, marking our twelfth consecutive quarter of year-over-year growth.”
Derek Schmidt, CEO of Flexsteel Industries, Inc.
“From a profitability standpoint, we delivered a GAAP operating margin of approximately 6 percent, which included a $0.8 million or 70 bps unfavorable foreign currency translation impact related to our peso-denominated asset exposure in Mexico.”
GrafTech International Ltd. finalized estimates for its previously announced permanent closure of its manufacturing facility in Monterrey, Mexico. The company expects to incur total non-cash charges of $25 million to $35 million, including $12.3 million in fixed asset write-offs, while maintaining its estimate of $20 million to $25 million in one-time cash expenditures.
Supernus Pharmaceuticals Deal Termination with UBS Bank USA
Supernus Pharmaceuticals terminated its uncommitted demand revolving credit line with UBS Bank USA on October 20, 2026. The termination was made in anticipation of the company's pending merger with Indivior Pharmaceuticals and the establishment of a new senior secured credit facility for the combined entity. There were no outstanding borrowings or early termination penalties associated with the cancellation.
Columbus McKinnon Corporation's Board of Directors declared a regular quarterly cash dividend of $0.07 per common share. The dividend is payable on November 16, 2026, to shareholders of record as of November 6, 2026.